A few years ago EFCCA launched a survey entitled BAB – Biologics and Biosimilars to assess patients knowledge about biosimilars and to find out to what extent patients are aware of the issues involved around biosimilars medicines.
We are now launching a follow up survey to see the evolution of patients perspectives on biosimilars now that they are widely used worldwide. The scientific coordinator of the BAB survey is Professor Laurent Peyrin- Biroulet - from the Department of Hepato-Gastroenterology CHU in Nancy, France.
The questionnaire is available in English, French, German, Italian, Portuguese and Spanish.
Questionnaire BAB English
Questionnaire BAB French
Questionnaire BAB German
Questionnaire BAB Italian
Questionnaire BAB Portuguese
Questionnaire BAB Spanish